1. Home
  2. LINC vs SYRE Comparison

LINC vs SYRE Comparison

Compare LINC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINC
  • SYRE
  • Stock Information
  • Founded
  • LINC 1946
  • SYRE 2013
  • Country
  • LINC United States
  • SYRE United States
  • Employees
  • LINC N/A
  • SYRE N/A
  • Industry
  • LINC Other Consumer Services
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINC Real Estate
  • SYRE Health Care
  • Exchange
  • LINC Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • LINC 729.2M
  • SYRE 841.4M
  • IPO Year
  • LINC 2005
  • SYRE 2016
  • Fundamental
  • Price
  • LINC $23.09
  • SYRE $16.55
  • Analyst Decision
  • LINC Strong Buy
  • SYRE Buy
  • Analyst Count
  • LINC 4
  • SYRE 6
  • Target Price
  • LINC $24.00
  • SYRE $55.00
  • AVG Volume (30 Days)
  • LINC 312.9K
  • SYRE 679.2K
  • Earning Date
  • LINC 08-07-2025
  • SYRE 08-06-2025
  • Dividend Yield
  • LINC N/A
  • SYRE N/A
  • EPS Growth
  • LINC N/A
  • SYRE N/A
  • EPS
  • LINC 0.39
  • SYRE N/A
  • Revenue
  • LINC $454,204,000.00
  • SYRE N/A
  • Revenue This Year
  • LINC $13.59
  • SYRE N/A
  • Revenue Next Year
  • LINC $8.08
  • SYRE N/A
  • P/E Ratio
  • LINC $58.78
  • SYRE N/A
  • Revenue Growth
  • LINC 15.24
  • SYRE N/A
  • 52 Week Low
  • LINC $11.22
  • SYRE $10.91
  • 52 Week High
  • LINC $24.20
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • LINC 55.92
  • SYRE 56.89
  • Support Level
  • LINC $22.05
  • SYRE $14.97
  • Resistance Level
  • LINC $23.29
  • SYRE $16.61
  • Average True Range (ATR)
  • LINC 0.92
  • SYRE 1.15
  • MACD
  • LINC -0.12
  • SYRE 0.01
  • Stochastic Oscillator
  • LINC 67.33
  • SYRE 77.51

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: